Ethanol induction of CYP2A5: permissive role for CYP2E1.
- Authors
- Lu, Yongke; Zhuge, Jian; Wu, Defeng; Cederbaum, Arthur I
- Year
- 2011
- Journal
- Drug metabolism and disposition: the biological fate of chemicals
- PMID
- 21051534
- DOI
- 10.1124/dmd.110.035691
- PMCID
- PMC3033694
CYP2A5 metabolizes xenobiotics and activates hepatocarcinogens, and induction occurs in response to hepatic damage and cellular stress. We evaluated whether ethanol can elevate CYP2A5 and whether CYP2E1 plays a role in the ethanol induction of CYP2A5. Wild-type (WT), CYP2E1 knockout (KO), and CYP2E1 knockin (KI) mice were fed ethanol for 3 weeks. Ethanol increased CYP2E1 and CYP2A5 protein and activity in WT mice but not in the KO mice. Induction of CYP2A5 (and CYP2E1) was restored in the KI mice. Ethanol induction of CYP2A5 occurred only after CYP2E1 was first induced. Immunohistochemical staining revealed that CYP2E1 and CYP2A5 colocalize to the same zones in the liver. Ethanol also elevated CYP2A5 mRNA levels in WT and KI mice but not in KO mice. Induction of CYP2A5 by cadmium was partially decreased in KO mice compared with WT or KI mice. Ethanol elevated CYP2A4 mRNA levels in all mice although the extent of induction was lowest in the KO mice. In summary, ethanol elevated mouse hepatic CYP2A5 levels, which may be of toxicological significance because CYP2A5 metabolizes nicotine and other drugs and activates hepatocarcinogens. Induction of CYP2A5 by ethanol is potentiated by the induction of CYP2E1. We speculate that ethanol induction of CYP2E1 followed by increases in reactive oxygen species and activation of Nrf2 are important steps in the mechanism by which ethanol induces CYP2A5. The possibility that induction of CYP2E1 is permissive for the induction of CYP2A5 may reflect a new contribution by CYP2E1 to the actions of ethanol.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury. | Wu Q et al. | β | 2025 | β |
| Effects of Chronic Alcohol Intake on the Composition of the Ensemble of Drug-Metabolizing Enzymes and Transporters in the Human Liver. | Gaither KA et al. | β | 2025 | β |
| Induction of Cyp2e1 contributes to asparaginase-induced hepatocyte sensitization to lipotoxicity. | Zhu Y et al. | β | 2025 | β |
| Effects of alcohol consumption and tobacco smoking on the composition of the ensemble of drug metabolizing enzymes and transporters in human liver | Gaither KA et al. | β | 2024 | β |
| Interaction between fatty acid oxidation and ethanol metabolism in liver. | Lu Y et al. | β | 2024 | β |
| Unravelling the complexities of non-alcoholic steatohepatitis: The role of metabolism, transporters, and herb-drug interactions. | Somabattini RA et al. | β | 2024 | β |
| Differential Effects of Nicotine, Alcohol, and Coexposure on Neuroimmune-Related Protein and Gene Expression in Corticolimbic Brain Regions of Rats. | Randall CA et al. | β | 2023 | β |
| Alcohol induced hepatic retinoid depletion is associated with the induction of multiple retinoid catabolizing cytochrome P450 enzymes. | Ferdouse A et al. | β | 2022 | β |
| Gut Commensal Fungi Protect Against Acetaminophen-Induced Hepatotoxicity by Reducing <i>Cyp2a5</i> Expression in Mice. | He Z et al. | β | 2022 | β |
| Multi-omics integration reveals the hepatoprotective mechanisms of ursolic acid intake against chronic alcohol consumption. | Yan X et al. | β | 2022 | β |
| Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas. | Ye L et al. | β | 2021 | β |
| PPARΞ± agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase. | Chen X et al. | β | 2021 | β |
| PPARΞ± agonist WY-14,643 induces adipose atrophy and fails to blunt chronic ethanol-induced hepatic fat accumulation in mice lacking adipose FGFR1. | Xu Y et al. | β | 2021 | β |
| A prospective study of the association between rate of nicotine metabolism and alcohol use in tobacco users in the United States. | Roberts W et al. | β | 2020 | β |
| High-fat diet induces fibrosis in mice lacking CYP2A5 and PPARΞ±: a new model for steatohepatitis-associated fibrosis. | Chen X et al. | β | 2020 | β |
| Contributing Roles of CYP2E1 and Other Cytochrome P450 Isoforms in Alcohol-Related Tissue Injury and Carcinogenesis. | Song BJ et al. | β | 2019 | β |
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | Wang K et al. | β | 2019 | β |
| Suppressed hepatocyte proliferation via a ROS-HNE-P21 pathway is associated with nicotine- and cotinine-enhanced alcoholic fatty liver in mice. | Chen X et al. | β | 2019 | β |
| Cytochrome P450s and Alcoholic Liver Disease. | Lu Y et al. | β | 2018 | β |
| E-cigarettes: Impact of E-Liquid Components and Device Characteristics on Nicotine Exposure. | DeVito EE et al. | β | 2018 | β |
| Nicotine enhances alcoholic fatty liver in mice: Role of CYP2A5. | Chen X et al. | β | 2018 | β |
| Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARΞ±-FGF21 axis. | Chen X et al. | β | 2017 | β |
| Alcoholic Liver Disease: from CYP2E1 to CYP2A5. | Leung TM et al. | β | 2017 | β |
| Alcohol Upregulation of CYP2A5: Role of Reactive Oxygen Species. | Lu Y et al. | β | 2016 | β |
| An improved in vitro method for screening toxin and medicine targeting CYP2E1. | Wang M et al. | β | 2016 | β |
| Cessation of alcohol consumption decreases rate of nicotine metabolism in male alcohol-dependent smokers. | Gubner NR et al. | β | 2016 | β |
| The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference. | Hong F et al. | β | 2016 | β |
| Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice. | Hong F et al. | β | 2015 | β |
| Hepatoprotective effect of kaempferol against alcoholic liver injury in mice. | Wang M et al. | β | 2015 | β |
| Identification of Ethanol and 4-Nitroquinoline-1-Oxide Induced Epigenetic and Oxidative Stress Markers During Oral Cavity Carcinogenesis. | Urvalek AM et al. | β | 2015 | β |
| Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease. | Song BJ et al. | β | 2015 | β |
| Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. | Chenoweth MJ et al. | β | 2014 | β |
| Multifactorial comparative proteomic study of cytochrome P450 2E1 function in chronic alcohol administration. | Wang Y et al. | β | 2014 | β |
| Nicotine enhances ethanol-induced fat accumulation and collagen deposition but not inflammation in mouse liver. | Lu Y et al. | β | 2013 | β |
| Role of oxidative stress in the pathogenesis of alcohol-induced liver disease. | Sid B et al. | β | 2013 | β |
| A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: implications in oxidative stress in HIV + smokers. | Jin M et al. | β | 2012 | β |
| An LC-MS/MS method for concurrent determination of nicotine metabolites and the role of CYP2A6 in nicotine metabolite-mediated oxidative stress in SVGA astrocytes. | Ande A et al. | β | 2012 | β |
| Differential effects of nicotine treatment and ethanol self-administration on CYP2A6, CYP2B6 and nicotine pharmacokinetics in African green monkeys. | Ferguson CS et al. | β | 2012 | β |
| Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway. | Lu Y et al. | β | 2012 | β |
| Ethanol-mediated regulation of cytochrome P450 2A6 expression in monocytes: role of oxidative stress-mediated PKC/MEK/Nrf2 pathway. | Jin M et al. | β | 2012 | β |
| A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice. | Hollander MC et al. | β | 2011 | β |